All stock lists
Unlock the score
Phio Pharmaceuticals Corp. (NASDAQ:PHIO)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.87+0.01 (+1.64%)
Market cap
$10.1M
Insider Score
Analyst consensus
Listed since
May 10, 2012
Website
Insider Score
/ 100
PHIO Insider Score
Phio Pharmaceuticals Corp. has a live Insider Score.
Scored on 7 qualifying trades from 3 insiders in the last 90 days.
PHIO Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 1.00 K | 1.00 K | 1.48 M | 1.18 M | 1.07 M | 15.00 K |
| Gross Profit | -1.00 K | -1.00 K | -1.48 M | -1.18 M | -1.07 M | -15.00 K |
| SG&A Expense | 1.19 M | 1.37 M | 1.06 M | 1.32 M | 1.24 M | 986.00 K |
| R&D Expense | 3.08 M | 2.79 M | 1.48 M | 1.18 M | 1.07 M | 886.00 K |
| Operating Expenses | 4.27 M | 4.17 M | 1.06 M | 1.32 M | 1.24 M | 1.86 M |
| Operating Income | -4.27 M | -4.17 M | -2.53 M | -2.50 M | -2.31 M | -1.87 M |
| Pretax Income | -4.14 M | -4.00 M | -2.37 M | -2.39 M | -2.17 M | -1.77 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -4.14 M | -4.00 M | -2.37 M | -2.39 M | -2.17 M | -1.77 M |
| EPS (Basic) | -0.36 | -0.34 | -0.20 | -0.44 | -0.45 | -41070.15 |
| EPS (Diluted) | -0.36 | -0.34 | -0.20 | -0.44 | -0.45 | -41070.15 |
| Shares Outstanding | 11.62 M | 11.62 M | 11.62 M | 5.47 M | 4.79 M | 4.31 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.